Get started
THERMO FISHER SCIENTIFIC INC COM USD1THERMO FISHER SCIENTIFIC INC COM USD1THERMO FISHER SCIENTIFIC INC COM USD1

THERMO FISHER SCIENTIFIC INC COM USD1

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

0R0H trade ideas

looking at sub 500 levels just can't seem to find the bottomReading many timeframes and patterns, it's a simple concept along with good or bad fundamentals, and of course, the catalyst is to sell the news or buy the speculation. In this case, reading the chart, we see oscillators that are turning to the downside, we don't see confirmation of the bottom, we see moving averages about to turn bearish with a death cross, and we can see the buying pressure versus the room to continue selling on the stochastic. RSI, we also see that the volume dried up toward the end of the year; we see fib retracement continue to bounce up and down, creating an H&S pattern on the second try before its demise from 7 pivots at resistance in the 620 regions. It seems like a smaller area of distribution before the next leg, but I do see a break of 500. Short-term bears.
NYSE:TMOShort
by themoneyman80
TMO Thermo Fisher Scientific Inc. (TMO) is currently experiencing a mixed financial and market performance. Here is a technical analysis of the stock as of November 2024: 1. **Recent Performance**: TMO's Q3 2024 earnings per share (EPS) came in at $5.28, slightly exceeding analyst estimates of $5.25, with revenues of $10.60 billion, marginally below the $10.63 billion expectation. The company's revenues grew by 0.2% year-over-year, signaling stability despite broader sectoral challenges. 2. **Growth Outlook**: The company is positioned for future growth, with potential benefits from easing pandemic-related slowdowns, strengthening biotech and pharmaceutical markets, and improved global funding conditions. Analysts project a full-year EPS of approximately $21.67 for 2024. 3. **Valuation and Buybacks**: TMO is considered attractively valued near its bottom range, with a robust stock buyback plan of $4 billion announced recently, demonstrating confidence in long-term financial health. 4. **Key Ratios and Metrics**: Thermo Fisher's net margin is 14.48%, and its return on equity stands at 17.49%, indicating efficient management of resources. However, its stock shows some volatility, with a neutral momentum score under multi-factor models. 5. **Dividend**: The company declared a quarterly dividend of $0.39 per share (annualized yield of 0.30%), reflecting a conservative payout ratio of 9.78%. 6. **Market Sentiment**: TMO is regarded as a strong contender in the medical equipment sector, but its high valuation may deter some investors. Analysts suggest a fair value estimate of $610, marking potential upside from current levels. While Thermo Fisher remains a leader in the life sciences and diagnostics space, potential investors should weigh the stock's valuation against its long-term growth trajectory and current macroeconomic conditions.
NYSE:TMOLong
by lvaysberg
TMO mid term analysis: 2024 is at risk By using the wave analysis we can forecast the future move of the price from a statistical mathematical perspective on NYSE:TMO . A minimum of swing at 474 dollars was broken down, that swing is the checkpoint for a T+6 (2 years wave). As the wave was broken to the downside on the 12 of October only after 234 days, we might expect a new yearly wave, potentially in development, with short term opportunities to the upside, but by the end of the new yearly wave (July 2024/ February 2025), the price should go lower than 415 dollars.
NYSE:TMO
by TRADOMICS_
Another Short on ThermoFischer. TMOThis is a doubling up on our earlier idea. See the linked idea. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe.
NYSE:TMOShort
by Rykin_Capital